Diuretics in preterm infants;Diurétiques et prématuré

Archives de Pediatrie

Volumn 13, Issue 4, 2006, Pages 379-387

  Semama, D S ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Adverse effects; Diuretics; Infant; premature

Indexed keywords

CHLOROTHIAZIDE; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; METHYLXANTHINE; PLACEBO; SPIRONOLACTONE; SULFONAMIDE; THEOPHYLLINE; THIAZIDE DIURETIC AGENT; XANTHIC ACID DERIVATIVE;

ARTIFICIAL VENTILATION; DEHYDRATION; DIURESIS; DIURETIC THERAPY; DRUG INDICATION; DRUG SURVEILLANCE PROGRAM; ELECTROLYTE DISTURBANCE; HUMAN; HYPERCALCIURIA; HYPOCHLOREMIA; HYPOKALEMIA; HYPONATREMIA; INFANT MORTALITY; KIDNEY DISEASE; KIDNEY FAILURE; LENGTH OF STAY; LUNG DYSPLASIA; NEUROLOGIC DISEASE; NEWBORN DISEASE; OTOTOXICITY; OUTCOME ASSESSMENT; PARAMETER; PATENT DUCTUS ARTERIOSUS; PERINATAL ASPHYXIA; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; RISK BENEFIT ANALYSIS; SHORT SURVEY; TREATMENT DURATION; TREATMENT OUTCOME; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; REVIEW;

BRONCHOPULMONARY DYSPLASIA; DIURETICS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; KIDNEY FAILURE; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 33646040981     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2005.12.013     Document Type: Short Survey

References (65)

1. Laudignon N., Ciampi A., Coupal L., et al. Furosemide and ethacrynic acid: risk factors for the occurrence of serum electrolyte abnormalities and metabolic alkalosis in newborns and infants. Acta Paediatr. Scand. 78 (1989) 133-135
2. Witte M.K., Stork J.E., and Blumer J.L. Diuretic therapeutics in the pediatric patient. Am. J. Cardiol. 57 (1986) 44A-53A
3. Woo W.C., Dupont C., Colllinge J., et al. Effects of furosemide in the newborn. Clin. Pharmacol. Ther. 23 (1978) 266-271
4. Mirochnick M.H., Miceli J.J., Kramer P.A., et al. Furosemide pharmacokinetics in very low birth weight infants. J. Pediatr. 112 (1988) 653-657
5. Mirochnick M.H., Miceli J.J., Kramer P.A., et al. Renal response to furosemide in very low birth weight infants during chronic administration. Dev. Pharmacol. Ther. 15 (1990) 1-7
6. Ross B.S., Pollak A., and Oh W. The pharmacologic effects of furosemide therapy in the low-birth-weight infant. J. Pediatr. 92 (1978) 149-152
7. Yeh T.F., Raval D., John E., et al. Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days. Arch. Dis. Child. 60 (1985) 621-626
8. Vert P., Broquaire M., Legagneur M., et al. Pharmacokinetics of furosemide in neonates. Eur. J. Clin. Pharmacol. 22 (1982) 39-45
9. Jacinto J.S., Modanlou H.D., Crade M., et al. Renal calcification incidence in very low birth weight infants. Pediatrics 81 (1988) 31-35
10. Venkataraman P.S., Han B.K., Tsang R.C., et al. Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy. Am. J. Dis. Child. 137 (1983) 1157-1161
11. Gilsanz V., Fernal W., Reid B.S., et al. Nepholithiasis in premature infants. Radiology 154 (1985) 107-110
12. Schell-Feith E.A., Kist-van Holthe J.E., van Zwieten P.H., et al. Preterm neonates with nephrocalcinosis: natural course and renal function. Pediatr. Nephrol. 18 (2003) 1102-1108
13. Cranefield D.J., Odd D.E., Harding J.E., et al. High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone. Pediatr. Radiol. 34 (2004) 138-142
14. Pope IV J.C., Trusler L.A., Klein A.M., et al. The natural history of nephrocalcinosis in premature infants treated with loop diuretics. J. Urol. 156 (1996) 709-712
15. Ezzedeen F., Adelman R.D., and Ahlfors C.E. Renal calcification in preterm infants: patholophysiology and long-term sequelae. J. Pediatr. 113 (1988) 532-539
16. Saarela T., Lanning P., and Koivisto M. Prematurity associated nephrocalcinosis and kidney function in early childhood. Pediatr. Nephrol. 13 (1999) 886-890
17. Downing G.J., Egelhoff J.C., Daily D.K., et al. Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years. J. Pediatr. 120 (1992) 599-604
18. Brion L.P., Primhak R.A., and Yong W. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst. Rev. 2 (2001) (CD001694)
19. Rybak L.P. Pathophysiology of furosemide ototoxicity. J. Otolaryngol. 11 (1982) 127-133
20. Rais-Bahrami K., Majd M., Veszelovszky E., et al. Use of furosemide and neonatal intensive care survivors. Am. J. Perinatol. 21 (2004) 329-332
21. Turmen T., Thom P., Louridas A.T., et al. Protein binding and bilirubin displacing properties of bumetanide and furosemide. J. Clin. Pharmacol. 22 (1982) 551-556
22. Green T.P., Thompson T.R., Johnson D.E., et al. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory distress syndrome. N. Engl. J. Med. 308 (1983) 743-748
23. Yeh T.F., Shibli A., Leu S.T., et al. Early furosemide therapy in premature infants (≤ 2000 gm) with respiratory distress syndrome: a randomized controlled trial. J. Pediatr. 105 (1984) 603-609
24. Belik J., Spitzer A.R., Clark B.J., et al. Effect of early furosemide administration in neonates with respiratory distress syndrome. Pediatr. Pulmonol. 3 (1987) 219-225
25. Yeh T.F., Wilks A., Singh J., et al. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. J. Pediatr. 101 (1982) 433-437
26. McCann E.M., Lewis K., Deming D.D., et al. Controlled trial of furosemide therapy in infants with chronic lung disease. J. Pediatr. 106 (1985) 957-962
27. Kugelman A., Durand M., and Garg M. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia. Pediatrics 99 (1997) 71-75
28. Huet F., Semama D., Grimaldi M., et al. Effects of theophylline on renal insufficiency in neonates with respiratory distress syndrome. Intensive Care Med. 21 (1995) 511-514
29. Tulassay T., and Seri I. Acute oliguria in preterm infants with hyaline membrane disease: interaction of dopamine and furosemide. Acta Paediatr. Scand. 75 (1986) 420-424
30. Costanzo L.S. Localization of diuretic action in microperfused rat distal tubules: Ca and Na transport. Am. J. Physiol. 248 (1985) F527-F535
31. Atkinson S.A., Shah J.K., McGee C., et al. Mineral excretion in premature infants receiving various diuretic therapies. J. Pediatr. 113 (1988) 540-545
32. 2+ absorption in rabbit CNT. Am. J. Physiol. 261 (1991) F36-F43
33. Haycock G.B. The influence of sodium on growth in infancy. Pediatr. Nephrol. 7 (1993) 871-875
34. Al-Dahhan, Jannoun L., and Haycock G.B. Effect of salt supplementation of newborn premature infants on neurodevelopmental outcome at 10-13 years of age. Arch. Dis. Child. Fetal Neonatal Ed. 86 (2002) F210-F213
35. Bert S., Gouyon J.B., and Semama D.S. Calcium, sodium and potassium urinary excretion during the first five days of life in very preterm infants. Biol. Neonate 85 (2004) 37-41
36. Zawada Jr. E.T., Lee D.B., and Kleeman C.R. Causes of hypercalcemia. Postgrad. Med. 66 (1979) 91-100
37. Wennberg R.P., Rasmussen L.F., and Ahlfors C.E. Displacement of bilirubin from human albumin by three diuretics. J. Pediatr. 90 (1977) 647-650
38. Albersheim S.G., Solimano A.J., Sharma A.K., et al. Randomized, double-blind, controlled trial of long-term diuretic therapy for bronchopulmonary dysplasia. J. Pediatr. 115 (1989) 615-620
39. Engelhardt B., Blalock W.A., Donlevy S., et al. Effect of spironolactone-hydrochlorothiazide on lung function in infants with chronic bronchopulmonary dysplasia. J. Pediatr. 114 (1989) 619-624
40. Hobbins S.M., Fowler R.S., Rowe R.D., et al. Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease. Arch. Dis. Child. 56 (1981) 934-938
41. Hoffman D.J., Gerdes J.S., and Abbasi S. Pulmonary function and electrolyte balance following spironolactone treatment in preterm infants with chronic lung disease: a double-blind, placebo-controlled, randomized trial. J. Perinatol. 20 (2000) 41-45
42. Sonntag J., and Gaude M. Effect of dexamethasone and spironolactone therapy in calcium and phosphate homeostasis in premature infants with a birth weight under 1,500 g. Klin. Padiatr. 210 (1998) 354-357
43. Gillot I., Gouyon J.B., and Guignard J.P. Renal effects of caffeine in preterm infants. Biol. Neonate 58 (1990) 133-136
44. Lochan S.R., Adeniyi-Jones S., Assadi F.K., et al. Coadministration of theophylline enhances diuretic response to furosemide in infants during extracorporeal membrane oxygenation: a randomized controlled pilot study. J. Pediatr. 133 (1998) 86-89
45. Pretzlaff R.K., Vardis R.J., and Pollack M.M. Aminophylline in the treatment of fluid overload. Crit. Care Med. 27 (1999) 2782-2785
46. Bell M., Jackson E., Mi Z., et al. Low-dose theophylline increases urine output in diuretic-dependent critically ill children. Intensive Care Med. 24 (1998) 1099-1105
47. Zakauddin S., Leake R.D., and Trygstad C.M. Renal effects of theophylline in the premature infant. Clin. Res. 24 (1976) 196
48. Lin J.J., Churchill P.C., and Bidani A.K. Effect of theophylline on the initiation phase of postischemic acute renal failure in rats. J. Lab. Clin. Med. 108 (1986) 150-154
49. Gouyon J.B., and Guignard J.P. Theophylline prevents the hypoxemia induced renal hemodynamic changes in rabbits. Kidney Int. 33 (1988) 1078-1083
50. Osswald H., Schmitz H.J., and Heidenreich O. Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia. Pflügers Arch. 357 (1975) 323-333
51. Tagawa H., and Vander A.J. Effects of adenosine compounds on renal function and renin secretion in dogs. Circ. Res. 26 (1970) 327-338
52. Harkavy K.L., Scanlon J.W., and Jose P. The effects fo theophylline on renal function in the premature newborn. Biol. Neonate 35 (1979) 126-130
53. Zanardo V., Dani C., Trevisanuto D., et al. Methylxanthines increase renal calcium excretion in preterm infants. Biol. Neonate 68 (1995) 169-174
54. Cattarelli D, Spandrio M, Gasparoni A et al. A randomised, double-blind, placebo-controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome. Arch. Dis. Child Fetal Neonatal Ed. 2005 Oct 4 [Epub].
55. Peterson R.G., Simmons M.A., Rumack B.H., et al. Pharmacology of furosemide in the premature newborn infant. J. Pediatr. 97 (1980) 139-143
56. Scalais E., Papageorgiou A., and Aranda J.V. Effects of ethacrynic acid in the newborn infant. J. Pediatr. 104 (1984) 947-950
57. Brion L.P., and Campbell D.E. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants. Cochrane Database Syst. Rev. 3 (2001) (CD001148)
58. Brion L.P., and Soll R.F. Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst. Rev. 2 (2001) (CD001454)
59. Savage M.O., Wilkinson A.R., Baum J.D., et al. Frusemide in respiratory distress syndrome. Arch. Dis. Child. 50 (1975) 709-713
60. Green T.P., Johnson D.E., Bass J.L., et al. Prophylactic furosemide in severe respiratory distress syndrome: blinded prospective study. J. Pediatr. 112 (1988) 605-612
61. Lewis V., and Whitelaw A. Furosemide for transient tachypnea of the newborn. Cochrane Database Syst. Rev. 1 (2002) (CD003064)
62. Kao L.C., Durand D.J., Phillips B.L., et al. Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. J. Pediatr. 111 (1987) 439-444
63. Kao L.C., Durand D.J., Mc Crea R.C., et al. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J. Pediatr. 124 (1994) 772-781
64. Brion L.P., and Primhak R.A. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst. Rev. 1 (2002) (CD001453)
65. Brion L.P., Primhak R.A., and Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst. Rev. 1 (2002) (CD001817)